Related Experiment Video

Updated: Feb 3, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.7K

Pancreatic Cancer Gene Therapy Delivered by Nanoparticles

Trevin Kurtanich1, Nicole Roos1, Guanmeng Wang1

  • 11 Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA, USA.

SLAS Technology
|November 6, 2018
PubMed

Insights

Nanoparticles offer a promising solution for pancreatic cancer gene therapy by efficiently delivering genetic material like small interfering RNA (siRNA) and microRNA (miRNA), overcoming challenges of conventional treatments.

Area of Science:

  • Oncology
  • Nanomedicine
  • Gene Therapy

Background:

  • Pancreatic cancer is highly lethal and resistant to traditional treatments like surgery and chemotherapy.
  • Gene therapy shows potential but faces challenges with nucleic acid delivery due to charge and stability.
  • Nanoparticles can enhance gene therapy by improving circulation, reducing immune response, and enabling targeted delivery.

Purpose of the Study:

  • To review nanoparticle-based gene therapy strategies for pancreatic cancer.
  • To focus on small interfering RNA (siRNA), microRNA (miRNA), and gene augmentation (DNA) therapies.
  • To discuss the future clinical applications and challenges of these therapies.

Main Methods:

  • Review of current literature on nanoparticle-mediated gene delivery for pancreatic cancer.
  • Analysis of nanoparticle characteristics for improved circulation and targeting.
  • Examination of therapeutic strategies utilizing siRNA, miRNA, and DNA payloads.

Main Results:

  • Nanoparticles effectively encapsulate and deliver genetic material for pancreatic cancer treatment.
  • Functionalized nanoparticles demonstrate improved targeting and reduced immunogenicity.
  • Various nanoparticle formulations show promise in preclinical models.

Conclusions:

  • Nanoparticle-based gene therapy represents a significant advancement in treating pancreatic cancer.
  • Further research and clinical trials are needed to overcome existing challenges.
  • This approach holds potential for more effective and targeted pancreatic cancer interventions.
Keywords:
chemotherapygene therapymicroRNAnanobiotechnanotechnologypancreatic cancer

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

12.5K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K